Skip to content

CDR

CEO succession at Endo

CEO succession at Endo

Endo International plc has appointed Paul Campanelli, as president and chief executive officer, succeeding Rajiv De Silva, who is stepping down. Endo said Campanelli, who was president of its generic drugs and OTC business, takes the helm as president and CEO effective immediately.

Walgreens brings differentiation to beauty care

Walgreens brings differentiation to beauty care

With its “Beauty Differentiation” store concept, Walgreens is banking on its reach (about 8,200 stores), a mix of exclusive and premium brands, a high level of service, and an engaging shopping environment to become “America’s most loved beauty destination,” Lauren Brindley, group vice president and

Brindley: Walgreens is reinventing beauty

Brindley: Walgreens is reinventing beauty

Walgreens’ vision to recreate the beauty shopping experience is becoming a reality at many of its stores. Aiming to be the destination of choice for today’s beauty care consumers, the drug chain will bring its “Beauty Differentiation” concept to about 1,800 stores by end of calendar 2016.

Trump, Clinton part ways on health care policy

Trump, Clinton part ways on health care policy

With the 2016 presidential election drawing near, health care has emerged as a policy area in which the two major candidates’ differences are strikingly clear. A useful starting point might be their respective approaches to prescription drug pricing.

EnvisionRx, Walgreens team up on 90-day scripts

Walgreens and EnvisionRx are launching a prescription drug program that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications.

Time of testing for Affordable Care Act looms

Time of testing for Affordable Care Act looms

The upcoming enrollment period for the Affordable Care Act will be pivotal, as hikes in premiums, withdrawals by insurance companies and sign-ups that fell short of targets have combined to call the law’s sustainability into question.

NACDS tabs senior VP of government affairs

The National Association of Chain Drug Stores has promoted Thomas O’Donnell to senior vice president of government affairs and public policy. O’Donnell reports to NACDS president and chief executive officer Steve Anderson.

WBA provides update on Rite Aid acquisition

WBA provides update on Rite Aid acquisition

Walgreens Boots Alliance Inc. (WBA) has upped the number of stores that it expects to divest to gain government clearance for its $17.2 billion purchase of Rite Aid Corp. WBA said this month that between 500 and 1,000 Walgreens and/or Rite Aid stores will probably have to be divested to win Federal

Barra, Foulkes on most powerful women list

CVS Pharmacy president Helena Foulkes and Walgreens Boots Alliance Inc. co-chief operating officer Ornella Barra were among those recognized by Fortune magazine as the “Most Powerful Women” in business for 2016.

CVS med sync initiative eliminates barriers

CVS Health is celebrating the one-year anniversary of its ScriptSync medication synchronization program. The pharmacy service that enables patients who regularly take multiple medications to pick up eligible maintenance prescriptions in a monthly visit to a CVS Pharmacy store.

Report tracks in-store clinic surge

The number of retail health clinics in the United States has increased by 38% to 2,215 since 2011, mostly as a result of expansion of the concept by major drug store chains, according to a new report from Kalorama ­Information.

SDM supports women’s health

Shoppers Drug Mart (SDM) and its associate owners on September 10 kicked off the 15th annual Growing Women’s Health campaign, a monthlong effort to support women’s health. The retailer is collecting donations from customers, with the goal of gathering $3.3 million for local women’s health charities.

Lack of debate about health care troubling

Lack of debate about health care troubling

One of the more surprising aspects of the sad spectacle leading up to the election of a new president and new Congress in November is the lack of serious, sustained debate about health care.